Vulvodynia: A state-of-the-art consensus on definitions, diagnosis and management

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 51, Issue 6, 2006, Pages 447-456

  Bachmann, Gloria A ^a,b   Rosen, Raymond ^a   Finn, Vivian W ^a   Utian, Wulf H ^a   Ayers, Charletta ^a   Basson, Rosemary ^a   Binik, Yitzchak M ^a   Brown, Candace ^a   Foster, David C ^a   Gibbons, John M ^a   Goldstein, Irwin ^a   Graziottin, Alessandra ^a   Haefner, Hope K ^a   Harlow, Bernard L ^a   Spadt, Susan Kellogg ^a   Leiblum, Sandra R ^a   Masheb, Robin M ^a   Reed, Barbara D ^a   Sobel, Jack D ^a   Veasley, Christin ^a   Wesselmann, Ursula ^a   Witkin, Steven S ^a   more..

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b NONE   (United States)

Author keywords

Consensus workshop; Vulvar diseases; Vulvodynia

Indexed keywords

ANESTHETIC AGENT; ANTICONVULSIVE AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DULOXETINE; ESTROGEN; LIDOCAINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AROMATHERAPY; ARTICLE; BIOPSY; CHRONIC PAIN; CLINICAL EXAMINATION; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC APPROACH ROUTE; DIET RESTRICTION; DIET THERAPY; DISEASE COURSE; EDUCATION PROGRAM; ELECTROANALGESIA; EVIDENCE BASED MEDICINE; FEEDBACK SYSTEM; HEALTH EDUCATION; HERBAL MEDICINE; HUMAN; INFLAMMATION; LABORATORY TEST; LIFESTYLE; LONG TERM CARE; MEDICAL EDUCATION; MEDICAL RESEARCH; MENTAL HEALTH; NOMENCLATURE; PATHOPHYSIOLOGY; PATIENT EDUCATION; PHYSICAL EXAMINATION; PHYSIOTHERAPY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RESIDENCY EDUCATION; RISK FACTOR; SELF CARE; SEXUAL DYSFUNCTION; STANDARDIZATION; STRESS; TAI CHI; TREATMENT INDICATION; VULVODYNIA; WELLBEING;

EID: 33745214239     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Harlow BL, Stewart EG: A population-based assessment of chronic unexplained vulvar pain: Have we underestimated the prevalence of vulvodynia? J Am Med Womens Assoc 2003;58:82-88
2. Masheb R, Lozano C, Richman S, et al: On the reliability and validity of physician ratings for vulvodynia and the discriminant validity of its subtypes. Pain Med 2004;5:349-358
3. Reed BD, Gorenflo DW, Haefner H: Generalized vulvar dysesthesia versus vestibulodynia: Are they distinct diagnoses? J Reprod Med 2003;48:858-864
4. Moyal-Barracco M, Lynch PJ: 2003 ISSVD terminology and classification of vulvodynia: A historical perspective. J Reprod Med 2004;49:772-777
5. Wesselman U, Burnett AL, Heinberg LJ: The urogenital and rectal pain syndromes. Pain 1997;73:269-294
6. Gordon AS, Panahian-Jand M, McComb F, et al: Characteristics of women with vulvar pain disorders: Responses to a web-based survey. J Sex Marital Ther 2003;29:45-58
7. Caruso S, Agnello C, Intelisano G, et al: Sexual behavior of women taking low-dose oral contraceptive containing 15 microg ethinylestradiol/60 microg gestodene. Contraception 2004;69:237-240
8. Bornstein J, Goldschmid N, Sabo E: Hyperinnervation and mast cell activation may be used as histopathologic diagnostic criteria for vulvar vestibulitis. Gynecol Obstet Invest 2004;58:171-178
9. Witkin SS, Gerber S, Ledger WJ: Differential characterization of women with vulvar vestibulitis syndrome. Am J Obstet Gynecol 2002;187:589-594
10. Bohm-Starke N, Hilliges M, Brodda-Jansen G, et al: Psychophysical evidence of nociceptor sensitization in vulvar vestibulitis syndrome. Pain 2001;94:177-183
11. Foster DC, Sazenski TM, Stodgell CJ: Impact of genetic variation in interleukin-1 receptor antagonist and melanocortin-1 receptor genes on vulvar vestibulitis syndrome. J Reprod Med 2004;49:503-509
12. Theoharides TC, Cochrane DE: Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuroimmunol 2004;146:1-12
13. Reed BD, Advincula AP, Fonde KR, et al: Sexual activities and attitudes of women with vulvar dysesthesia. Obstet Gynecol 2003;102:325-331
14. Graziottin A: Female sexual dysfunction. In Evidence Based Physiology for the Pelvic Floor: Bridging Research and Clinical Practice. Edited by K Bo, B Berghmans, M van Kampen, et al. Oxford, Elsevier, 2005
15. Graziottin A, Brotto L: Vulvar vestibulitis syndrome: A clinical approach. J Sex Marital Ther 2004;30:125-139
16. Reed BD, Crawford S, Couper M, et al: Pain at the vulvar vestibule: A web-based survey. J Lower Genit Tract Dis 2004;8:48-57
17. Friedrich EG: Vulvar Disease. Philadelphia, WB Saunders, 1976
18. Friedrich EG: Vulvar vestibulitis syndrome. J Reprod Med 1987;32:110-114
19. Bergeron S, Binik YM, Khalife S, et al: Vulvar vestibulitis syndrome: Reliability of diagnosis and evaluation of current diagnostic criteria. Obstet Gynecol 2001;98:45-51
20. Pukall CF, Binik YM, Khalife S, et al: Vestibular tactile and pain thresholds in women with vulvar vestibulitis syndrome. Pain 2002;96:163-175
21. Curnow JS, Barron L, Morrison G, et al: Vulval algesiometer. Med Biol Eng Comput 1996;34:266-269
22. Reid R, Greenberg MD, Daoud Y, et al: Colposcopic findings in women with vulvar pain syndromes: A preliminary report. J Reprod Med 1988;33:523-532
23. Tchoudomirova K, Mårdh PA, Hellberg D: Vaginal microbiological flora, and behavioral and clinical findings in women with vulvar pain. Br J Obstet Gynaecol 2001;108:451-455
24. McKay M: Dysesthetic ("essential") vulvodynia: Treatment with amitriptyline. J Reprod Med 1993;38:9-13
25. Munday PE: Response to treatment in dysaesthetic vulvodynia. J Obstet Gynaecol 2001;6:610-613
26. Haefner H, Collins ME, Davis GC, et al: The vulvodynia guidelines. J Lower Genital Tract Dis 2005;9:40-51
27. Ben-David B, Friedman M: Gabapentin therapy for vulvodynia. Anesth Anal 1999;89:1459-1460
28. Murina F, Tassan P, Roberti P, et al: Treatment of vulvar vestibulitis with submucous infiltrations of methylprednisolone and lidocaine: An alternative approach. J Reprod Med 2001;46:713-716
29. Foster EXI, Palmer M, Marks J: Effect of vulvovaginal estrogen on sensorimotor response of the lower genital tract: A randomized controlled trial. Obstet Gynecol 1999;94:232-237
30. Zolnoun DA, Hartmann KE, Steege JF: Overnight 5% lidocaine ointment for treatment of vulvar vestibulitis. Obstet Gynecol 2003;102:84-87
31. Solomons CC, Melmed MH, Heitler SM: Calcium citrate for vulvar vestibulitis: A case report. J Reprod Med 1991;36:879-882
32. Bergeron S, Brown C, Lord MJ, et al: Physical therapy for vulvar vestibulitis syndrome: A retrospective study. J Sex Marital Ther 2002;28:183-192
33. Glazer HI, Rodke G, Swencionis C, et al: Treatment of vulvar vestibulitis syndrome with electromyographic biofeedback of pelvic floor musculature. J Reprod Med 1995;40:283-290
34. Vincenti E, Graziottin A: Sexual pain disorders: Management by anesthesia. In Women's Sexual Function and Dysfunction: Study, Diagnosis and Treatment. Edited by I Goldstein, C Meston, S Davis, et al. London, Taylor and Francis, 2005
35. Haefner KH: Critique of new gynecologic surgical procedures: Surgery for vulvar vestibulitis. Clin Obstet Gynecol 2000;43:689-700
36. Bergeron S, Binik YM, Khalife S, et al: A randomized comparison of group cognitive-behavioral therapy, surface electromyographic biofeedback, and vestibulectomy in the treatment of dyspareunia resulting from vulvar vestibulitis. Pain 2001;91:297-306
37. Haefner HK, Collins ME, Davis GD, et al: The vulvodynia guideline. J Lower Genit Tract Dis 2005;9:40-51
38. Babula O, Danielsson I, Sjoberg I, et al: Altered distribution of mannose-binding lectin alleles at exon 1 codon 54 in women with vulvar vestibulitis syndrome. Am J Obstet Gynecol 2004;191:762-766
39. Sobel JD, Wiesenfeld HC, Martens M, et al: Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med 2004;351:876-883